Back to News
Market Impact: 0.15
electroCore Targets 2027 EBITDA Profit as VA, Quell and CIPN Opportunities Expand
Source: marketbeat.com
Healthcare & BiotechCorporate Guidance & OutlookCompany Fundamentals
electroCore co-CEO, president and CFO Joshua Lev said the company plans to broaden its federal-market presence and expand product indications. The commercial-stage bioelectronic health and wellness company is targeting adjusted EBITDA profitability in the second half of 2027.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
ECOR0.10
More News
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- SK Hynix says the memory-chip shortage will last until 2030—and more than half its production is booked for the next two years
- China’s tech darlings are losing their shine. Here’s what’s behind the sell-off
- GE Vernova shares slip despite a beat-and-raise. What the sellers are getting wrong
- Microsoft’s strong quarter backs up its stock rebound. Here's our new price target